UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q2 2022 | 2022-08-15 | Future report Set alerts | |
| Q1 2022 | 2022-05-11 | -0.04 | -0.04 |
| Q4 2021 | 2022-03-28 | -0.03 | -0.03 |
| Q3 2021 | 2021-11-10 | -0.03 | -0.03 |
| Q2 2021 | 2021-08-16 | -0.02 | -0.02 |
| Q1 2021 | 2021-05-13 | -0.02 | -0.02 |
| Q4 2020 | 2021-03-23 | -0.03 | -0.03 |
| Q3 2020 | 2020-11-09 | -0.04 | -0.04 |
| Q2 2020 | 2020-08-10 | -0.03 | -0.03 |
| Q1 2020 | 2020-05-11 | -0.05 | -0.05 |
| 2016-05-17 | Reiterated Rating | Jefferies Group | Hold | $1.00 to $0.75 |
| 2016-05-14 | Reiterated Rating | Piper Jaffray | Overweight | $2.00 to $1.00 |
| 2016-05-14 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $2.00 to $1.00 |
| 2016-03-16 | Initiated Coverage | Rodman & Renshaw | Buy | $3.50 |
| 2016-03-16 | Reiterated Rating | HC Wainwright | Buy | |
| 2016-03-11 | Reiterated Rating | Jefferies Group | Hold | $1.50 |
| 2015-12-31 | Reiterated Rating | Roth Capital | Buy to Not Rated | $15.00 |
| 2015-05-20 | Downgrade | Jefferies Group | Buy to Hold | |
| 2014-09-04 | Reiterated | Stifel | Buy | $16 to $10 |
| 2014-09-04 | Lower Price Target | Stifel Nicolaus | Buy | $16.00 to $10.00 |
| 2014-08-08 | Downgrade | Robert W. Baird | Outperform to Neutral | $15.00 to $12.00 |
| 2014-08-08 | Downgrade | Piper Jaffray | Overweight to Neutral | $19.00 to $11.00 |
| 2014-06-30 | Initiated Coverage | Robert W. Baird | Outperform | $15.00 |
| 2014-06-09 | Lower Price Target | Jefferies Group | Buy | $23.00 to $18.00 |
| 2013-11-11 | Reiterated Rating | Stifel Nicolaus | Buy | $17.00 to $19.00 |
| 2013-10-03 | Boost Price Target | Jefferies Group | Buy | $17.00 to $23.00 |
| 2016-05-17 | Reiterated Rating | Jefferies Group | Hold | $1.00 to $0.75 |
| 2016-05-14 | Reiterated Rating | Piper Jaffray | Overweight | $2.00 to $1.00 |
| 2016-05-14 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $2.00 to $1.00 |
| 2016-03-16 | Initiated Coverage | Rodman & Renshaw | Buy | $3.50 |
| 2016-03-16 | Reiterated Rating | HC Wainwright | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MBII 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| WADDELL & REED FINANCIAL INC 1 | 101.29% (24714892) | MBII / |
| ARDSLEY ADVISORY PARTNERS | 42.41% (10348247) | MBII / SABA / |
| VAN HERK INVESTMENTS B.V. | 29.28% (7144148) | MBII / |
| Syngenta Ventures Pte. Ltd. | 7.75% (1889877) | MBII / |
| STUART MILL VENTURE PARTNERS LP 10% stockholder | 5.49% (1338388) | MBII / |
| Bhatia Ranjeet | 4.49% (1096201) | MBII / |
| Marrone Pamela G CEO and President | 3.24% (790309) | MBII / |
| Rominger Richard E | 0.45% (109522) | MBII / |
| BENOFF MICHAEL H | 0.37% (89773) | MBII / |
| Merrigan Kathleen | 0.31% (76732) | MBII / |
| BOYD JAMES Chief Financial Officer | 0.17% (41250) | MBII / PSEM / |
| Miller Elin D | 0.07% (17895) | MBII / |
| Contag Pamela Reilly | 0.07% (17895) | DCTH / MBII / |
| Stanley Shaugn | 0.04% (10438) | MBII / |
| Johnson Timothy B VP Field Development Technical | 0.04% (10000) | MBII / |
| KERCKHOVE GEORGE H | 0.01% (3000) | MBII / |
UM